Chengda Ren1, Qingyu Liu1, Qingquan Wei2, Wenting Cai1, Mengmei He1, Yaru Du3, Ding Xu1, Yan Wu4, Jing Yu1. 1. Department of Ophthalmology, Shanghai Tenth people's hospital, Tongji University School of Medicine, Shanghai, China. 2. Department of Ophthalmology, Shanghai Tenth people's hospital, Nanchang University, Nanchang, China. 3. Department of Ophthalmology, Shanghai Tenth People's hospital, Department of First Clinical Medical College, Nanjing Medical University, Nanjing, China. 4. Department of Ophthalmology, First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract
Backgroud: Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness of the elder people. This research was intended to demonstrate the different expression of microRNAs (miRNA) in AMD patients and whether they can be used as biomarkers for AMD. METHODS: MiRNAs expression was measured by microarray of 6 AMD cases and 6 gender matched controls. In a larger-sample case-control study with 126 AMD cases and 140 controls, whole blood samples were detected for the differences of miRNA expression. RESULTS: A total of 216 differentially expressed miRNAs (111 increased and 105 decreased miRNAs) were detected from circulating miRNA microarray. Expanded case-control study results showed that the expression of miR-27a-3p, miR-29b-3p and miR-195-5p was increased significantly. Moreover, the level of miR-27a is higher in patients with wet AMD compared to patients with dry AMD. All 3 miRNAs showed a potential diagnostic value for AMD. CONCLUSION: Circulating miRNA levels were significantly varied in AMD patients. Three miRNAs, miR-27a-3p, miR-29b-3p and the miR-195-5p, might be potential diagnostic biomarkers for AMD.
Backgroud: Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness of the elder people. This research was intended to demonstrate the different expression of microRNAs (miRNA) in AMDpatients and whether they can be used as biomarkers for AMD. METHODS: MiRNAs expression was measured by microarray of 6 AMD cases and 6 gender matched controls. In a larger-sample case-control study with 126 AMD cases and 140 controls, whole blood samples were detected for the differences of miRNA expression. RESULTS: A total of 216 differentially expressed miRNAs (111 increased and 105 decreased miRNAs) were detected from circulating miRNA microarray. Expanded case-control study results showed that the expression of miR-27a-3p, miR-29b-3p and miR-195-5p was increased significantly. Moreover, the level of miR-27a is higher in patients with wet AMD compared to patients with dry AMD. All 3 miRNAs showed a potential diagnostic value for AMD. CONCLUSION: Circulating miRNA levels were significantly varied in AMDpatients. Three miRNAs, miR-27a-3p, miR-29b-3p and the miR-195-5p, might be potential diagnostic biomarkers for AMD.
Authors: Hanan ElShelmani; Michael A Wride; Tahira Saad; Sweta Rani; David J Kelly; David Keegan Journal: Transl Vis Sci Technol Date: 2020-03-30 Impact factor: 3.283
Authors: Zeljka Smit-McBride; Johnny Nguyen; Garrett W Elliott; Zhe Wang; Ryan A McBride; Anthony T Nguyen; Sharon L Oltjen; Glenn Yiu; Sara M Thomasy; Kent E Pinkerton; Eugene S Lee; David Cunefare; Sina Farsiu; Lawrence S Morse Journal: Mol Vis Date: 2018-09-24 Impact factor: 2.367
Authors: Christina Kiel; Patricia Berber; Marcus Karlstetter; Alexander Aslanidis; Tobias Strunz; Thomas Langmann; Felix Grassmann; Bernhard H F Weber Journal: Int J Mol Sci Date: 2020-04-13 Impact factor: 5.923
Authors: Maria Oltra; Lorena Vidal-Gil; Rosa Maisto; Javier Sancho-Pelluz; Jorge M Barcia Journal: J Cell Mol Med Date: 2019-12-21 Impact factor: 5.310